Wambolt & Associates, LLC Pfizer Inc Transaction History

Wambolt & Associates, LLC

$310 Million
Q4 2024

A detailed history of Wambolt & Associates, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Wambolt & Associates, LLC holds 7,644 shares of PFE stock, worth $193,698. This represents 0.07% of its overall portfolio holdings.

Number of Shares

7,644

Previous 10,203 25.08%

Holding current value

$193,698

Previous $295,000 31.53%

% of portfolio

0.07%

Previous 0.08%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 11, 2025	SELL	$24.8 - $30.19 $63,463 - $77,256	-2,559 Reduced 25.08%	7,644 $202,000
Q3 2024 Nov 08, 2024	SELL	$27.7 - $31.39 $130,550 - $147,941	-4,713 Reduced 31.6%	10,203 $295,000
Q2 2024 Aug 07, 2024	SELL	$25.26 - $29.6 $95,710 - $112,154	-3,789 Reduced 20.26%	14,916 $417,000
Q1 2024 Apr 30, 2024	SELL	$25.89 - $29.73 $500,557 - $574,799	-19,334 Reduced 50.83%	18,705 $519,000
Q4 2023 Feb 07, 2024	SELL	$26.13 - $33.94 $339,271 - $440,676	-12,984 Reduced 25.45%	38,039 $1.1 Million
Q3 2023 Nov 06, 2023	BUY	$32.09 - $37.51 $50,894 - $59,490	1,586 Added 3.21%	51,023 $1.69 Million
Q2 2023 Aug 02, 2023	SELL	$36.12 - $41.79 $108,829 - $125,913	-3,013 Reduced 5.74%	49,437 $1.81 Million
Q1 2023 May 05, 2023	BUY	$39.39 - $51.28 $590 - $769	15 Added 0.03%	52,450 $2.14 Million
Q4 2022 Jan 31, 2023	BUY	$41.75 - $54.5 $11,690 - $15,260	280 Added 0.54%	52,435 $2.69 Million
Q3 2022 Oct 18, 2022	SELL	$43.76 - $53.42 $4,726 - $5,769	-108 Reduced 0.21%	52,155 $2.28 Million
Q2 2022 Aug 01, 2022	BUY	$46.53 - $55.17 $123,490 - $146,421	2,654 Added 5.35%	52,263 $2.74 Million
Q1 2022 May 10, 2022	SELL	$45.75 - $56.69 $39,711 - $49,206	-868 Reduced 1.72%	49,609 $2.56 Million
Q4 2021 Feb 08, 2022	BUY	$41.32 - $61.25 $82,805 - $122,745	2,004 Added 4.13%	50,477 $2.98 Million
Q3 2021 Oct 20, 2021	BUY	$39.25 - $50.42 $195,857 - $251,595	4,990 Added 11.48%	48,473 $2.08 Million
Q2 2021 Aug 13, 2021	BUY	$35.91 - $40.68 $95,017 - $107,639	2,646 Added 6.48%	43,483 $1.72 Million
Q1 2021 Apr 19, 2021	BUY	$33.49 - $37.77 $120,363 - $135,745	3,594 Added 9.65%	40,837 $1.48 Million
Q4 2020 Jan 19, 2021	BUY	$33.47 - $42.56 $260,095 - $330,733	7,771 Added 26.37%	37,243 $1.37 Million
Q3 2020 Nov 04, 2020	BUY	$31.75 - $37.25 $143,256 - $168,072	4,512 Added 18.08%	29,472 $1.08 Million
Q2 2020 Jul 23, 2020	BUY	$30.12 - $36.54 $232,677 - $282,271	7,725 Added 44.82%	24,960 $816,000
Q1 2020 May 11, 2020	BUY	$27.03 - $38.62 $15,515 - $22,167	574 Added 3.45%	17,235 $563,000
Q4 2019 Feb 10, 2020	BUY	$32.92 - $37.36 $41,182 - $46,737	1,251 Added 8.12%	16,661 $653,000
Q3 2019 Oct 15, 2019	SELL	$32.49 - $42.13 $2,274 - $2,949	-70 Reduced 0.45%	15,410 $554,000
Q2 2019 Jul 26, 2019	BUY	$36.98 - $41.52 $85,793 - $96,326	2,320 Added 17.63%	15,480 $671,000
Q1 2019 Apr 11, 2019	BUY	$37.5 - $41.2 $71,587 - $78,650	1,909 Added 16.97%	13,160 $564,000
Q4 2018 Jan 29, 2019	BUY	$38.47 - $43.86 $432,825 - $493,468	11,251 New	11,251 $491,000

Others Institutions Holding PFE

# of Institutions

3,373

Shares Held

3.56B

Call Options Held

106M

Put Options Held

123M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $142B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wambolt & Associates, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wambolt & Associates, LLC with notifications on news.

Account

Wambolt & Associates, LLC Pfizer Inc Transaction History